Behavioral problems in dementia - Strategies for pharmacologic and nonpharmacologic management

被引:2
作者
Smith, AG
机构
[1] USF, Suncoast Gerontol Ctr, Tampa, FL 33617 USA
[2] USF, Coll Med, Dept Psychiat & Behav Med, Tampa, FL 33617 USA
关键词
D O I
10.3810/pgm.2004.06.1536
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Behavioral disturbances in Alzheimer's disease and related disorders are common throughout all stages of these dementing illnesses. They are a major source of caregiver distress and can lead to premature institutionalization of the patient if not properly addressed. Fortunately, such behaviors are often treatable. In this article, Dr Smith outlines ways to manage behavioral problems in dementia with pharmacologic as well as nonpharmacologic approaches. Throughout, she emphasizes that proper treatment of problem behaviors in this vulnerable population requires the education and patience of caregivers and physicians alike.
引用
收藏
页码:47 / +
页数:8
相关论文
共 15 条
  • [1] ALEXOPOULOS GS, TREATMENT DEPRESSION, P184
  • [2] AVORN J, 1998, CLIN GERIATRIC PSYCH, P34
  • [3] Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia:: The results of a double-blind, placebo-controlled trial with Melissa
    Ballard, CG
    O'Brien, JT
    Reichelt, K
    Perry, EK
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (07) : 553 - 558
  • [4] Cummings JL., 2003, NEUROPSYCHIATRY BEHA, P16
  • [5] Desai Abhilash K., 2001, Prim Care Companion J Clin Psychiatry, V3, P93
  • [6] Finkel SI, 2001, J CLIN PSYCHIAT, V62, P3
  • [7] A review of Feil's validation method for communicating with and caring for dementia sufferers
    Jones, GMM
    [J]. CURRENT OPINION IN PSYCHIATRY, 1997, 10 (04) : 326 - 332
  • [8] KAHN DA, 1998, J PRACT PSYCH BEHAV, V5, P265
  • [9] LANTZ MS, 2003, CLIN GERIATR MED, V11, P34
  • [10] Allopurinol for the treatment of aggressive behaviour in patients with dementia
    Lara, DR
    Cruz, MRS
    Xavier, F
    Souza, DO
    Moriguchi, EH
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (01) : 53 - 55